| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.49 | 0.08 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.46 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |